Halozyme Therapeutics Ratios (2010-2026) | HALO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	83.13%	83.95%	78.84%	86.42%	77.72%	77.36%	76.79%	78.31%	77.35%	74.62%	77.27%	85.54%	82.88%	82.96%	85.89%	81.73%	85.77%	84.41%	82.56%	78.97%
EBT Margin (Quarter)	67.07%	63.98%	53.73%	63.45%	19.70%	35.27%	39.00%	32.22%	42.14%	47.10%	43.98%	49.02%	50.89%	56.93%	59.80%	54.30%	62.92%	61.81%	-22.32%	47.87%
EBIT Margin (Quarter)	68.19%	65.26%	55.42%	64.52%	22.35%	39.86%	41.05%	33.18%	42.73%	40.86%	43.92%	48.78%	50.67%	56.26%	58.89%	53.44%	62.15%	61.51%	-20.56%	48.98%
EBITDA Margin (Quarter)	68.19%	65.26%	55.42%	64.52%	22.35%	39.86%	41.05%	33.18%	42.73%	40.86%	43.92%	48.78%	50.67%	56.26%	58.89%	53.44%	62.15%	61.51%	-20.56%	48.98%
Operating Margin (Quarter)	68.19%	65.26%	55.42%	64.52%	22.35%	39.86%	41.05%	33.18%	42.73%	40.86%	43.92%	48.78%	50.67%	56.26%	58.89%	53.44%	62.15%	61.51%	-20.56%	48.98%
Net Margin (Quarter)	67.02%	186.99%	65.46%	51.25%	14.89%	29.49%	31.79%	24.43%	33.82%	37.88%	37.12%	39.22%	40.30%	47.23%	45.98%	44.59%	50.71%	49.47%	-31.34%	39.83%
FCF Margin (Quarter)	26.64%	104.67%	82.10%	40.49%	25.65%	32.84%	44.14%	53.39%	30.12%	61.35%	38.08%	64.27%	25.43%	37.31%	62.36%	57.87%	30.13%	49.56%	48.17%	46.81%
Efficiency
Inventory Average (Quarter)	58.45M	57.27M	54.94M	50.83M	72.69M	100.45M	101.70M	103.82M	119.96M	130.66M	128.26M	148.07M	163.93M	145.36M	136.64M	153.36M	173.19M	183.65M	181.14M	165.97M
Assets Average (Quarter)	996.22M	1,105.64M	1,144.92M	1,133.34M	1,471.82M	1,822.97M	1,853.03M	1,770.48M	1,754.94M	1,851.55M	1,812.97M	1,787.40M	1,905.49M	2,043.74M	2,090.75M	2,130.00M	2,125.22M	2,137.57M	2,373.28M	2,599.02M
Invested Capital (Quarter)	89.17M	89.25M	89.42M	89.55M	99.05M	13.31M	13.33M											710.68M		208.74M
Asset Utilization Ratio (Quarter)	0.41	0.42	0.39	0.42	0.33	0.32	0.36	0.40	0.44	0.42	0.46	0.48	0.46	0.46	0.49	0.51	0.55	0.58	0.59	0.58
Leverage & Solvency
Interest Coverage Ratio (Quarter)	53.11	43.09	27.51	43.02	10.97	11.08	16.30	11.84	21.02	19.60	27.24	21.20	25.91	36.07	38.66	31.28	46.07	6.00	11.09	33.50
Debt Ratio (Quarter)	0.85	0.74	0.79	0.76	0.70	0.81	0.83	0.88	0.83	0.79	0.86	0.82	0.76	0.71	0.73	0.69	0.73	0.68	0.85	0.80
Times Interest Earned (Quarter)	53.11	43.09	27.51	43.02	10.97	11.08	16.30	11.84	21.02	19.60	27.24	21.20	25.91	36.07	38.66	31.28	46.07	6.00	11.09	33.50
Valuation
Enterprise Value (Quarter)	-755.31M	-815.92M	-740.92M	-786.14M	-209.36M	-265.58M	-362.79M	-275.61M	-348.27M	-483.28M	-336.00M	-463.45M	-529.03M	-666.31M	-596.07M	-747.92M	-548.18M	-701.96M	-142.82M	-318.62M
Return Ratios
Return on Sales (Quarter)	0.01%	0.02%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	29.67%	29.92%	26.84%	29.45%	19.01%	14.56%	15.53%	14.64%	18.68%	17.91%	19.85%	22.91%	22.69%	24.65%	28.26%	30.18%	34.29%	56.71%	21.36%	22.90%
Return on Invested Capital (Quarter)	0.00%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.03%	0.12%									0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Halozyme Therapeutics Ratios (2010-2026) | HALO

Research Tools

Developers

Halozyme Therapeutics Ratios (2010-2026) | HALO

Create an account

Sign In

Reset Password